ALPS Advisors’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,476
Closed -$1.16M 1013
2023
Q1
$1.16M Sell
2,476
-72
-3% -$33.6K 0.01% 432
2022
Q4
$1.02M Buy
2,548
+500
+24% +$200K 0.01% 476
2022
Q3
$666K Sell
2,048
-166
-7% -$54K 0.01% 549
2022
Q2
$585K Sell
2,214
-1,609
-42% -$425K 0.01% 555
2022
Q1
$1.15M Sell
3,823
-469
-11% -$141K 0.01% 298
2021
Q4
$1.51M Sell
4,292
-249
-5% -$87.8K 0.02% 318
2021
Q3
$1.16M Sell
4,541
-293
-6% -$74.8K 0.01% 375
2021
Q2
$3.22M Sell
4,834
-1,792
-27% -$1.19M 0.03% 210
2021
Q1
$5.75M Buy
6,626
+93
+1% +$80.7K 0.06% 171
2020
Q4
$6.06M Buy
6,533
+1,924
+42% +$1.78M 0.07% 166
2020
Q3
$4.74M Sell
4,609
-253
-5% -$260K 0.07% 164
2020
Q2
$4.93M Sell
4,862
-1,465
-23% -$1.48M 0.07% 153
2020
Q1
$5.5M Sell
6,327
-702
-10% -$610K 0.09% 140
2019
Q4
$7.54M Buy
7,029
+96
+1% +$103K 0.06% 132
2019
Q3
$6.41M Sell
6,933
-256
-4% -$237K 0.05% 131
2019
Q2
$8.12M Buy
7,189
+1,030
+17% +$1.16M 0.06% 125
2019
Q1
$8.37M Sell
6,159
-1,697
-22% -$2.31M 0.06% 130
2018
Q4
$9.09M Buy
7,856
+1,887
+32% +$2.18M 0.07% 119
2018
Q3
$9.07M Buy
5,969
+1,142
+24% +$1.73M 0.06% 125
2018
Q2
$7.55M Buy
4,827
+427
+10% +$668K 0.05% 132
2018
Q1
$5.08M Buy
4,400
+765
+21% +$884K 0.04% 146
2017
Q4
$4.31M Buy
3,635
+515
+17% +$610K 0.03% 147
2017
Q3
$4.2M Buy
3,120
+595
+24% +$800K 0.03% 149
2017
Q2
$2.04M Buy
2,525
+352
+16% +$284K 0.01% 185
2017
Q1
$1.34M Sell
2,173
-255
-11% -$157K 0.01% 196
2016
Q4
$1.3M Sell
2,428
-774
-24% -$414K 0.01% 199
2016
Q3
$1.66M Sell
3,202
-307
-9% -$159K 0.01% 195
2016
Q2
$1.44M Buy
3,509
+750
+27% +$308K 0.01% 193
2016
Q1
$1.47M Sell
2,759
-473
-15% -$252K 0.02% 169
2015
Q4
$2.46M Sell
3,232
-479
-13% -$365K 0.02% 161
2015
Q3
$20.3K Buy
3,711
+1,357
+58% +$7.44K 0.02% 170
2015
Q2
$1.38M Buy
+2,354
New +$1.38M 0.01% 190